Pharma's digital revolution is well underway, and Sandoz is placing some big bets that tech can transform the company—and everything it does.
The Novartis generics business is taking on digital and data technologies from discovery and development all the way to commercialization, believing the approach can open up healthcare access and improve patient outcomes.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,